Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302626 · ClinicalTrials.gov registry record
Radiomics: a Study of Outcome in Lung Cancer
A clinical trial, sponsored by Maastricht Radiation Oncology.
- Completed
- Registry status
- 216
- Enrollment target
NCT01302626 is a clinical trial that has completed, run by Maastricht Radiation Oncology. The registered enrollment target is 216 participants.
The verdict
NCT01302626 has completed, sponsored by Maastricht Radiation Oncology.
- COMPLETED
- Registry status
- 216 participants
- Enrollment target
Study Summary
Aim of the study: The main aim is to collect data of patients with lung cancer, and to perform different analyses on this data. The data contains information on patient and tumor characteristics, imaging, and treatment characteristics. With this data it is possible to improve and validate the predictive model for survival and long term toxicity in lung cancer by multicentric prospective data collection. The long term aim, beyond this specific study, is to build a Decision Support System based on the predictive models validated in this study. Hypothesis: The general hypothesis is that we get a better prediction in terms of AUC (area under the curve) of survival and long term toxicity when we combine multifactorial variables. These variables consist of information from clinical data, imaging data, data related to treatment type and treatment quality.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01302626
The ClinicalTrials.gov registry entry for NCT01302626 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maastricht Radiation Oncology, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01302626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01302626 about?
NCT01302626 is a clinical study titled "Radiomics: a Study of Outcome in Lung Cancer". Aim of the study: The main aim is to collect data of patients with lung cancer, and to perform different analyses on this data. The data contains information on patient and tumor characteristics, imaging, and treatment characteristics. With this data it is possible to improve and validate the predic...
What is the current status of trial NCT01302626?
This trial is currently completed. The enrollment target is 216 participants. The study started on 2010-03. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT01302626?
This trial is sponsored by Maastricht Radiation Oncology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.